Biotechnology

RedHill Biopharma Reports Second Quarter 2021 Financial Results and Operational Highlights

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (NASDAQ: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today reported its financial results and operational highlights for the second quarter...

2021-08-26 19:56 7626

RedHill Biopharma's Opaganib Demonstrates Strong Inhibition of COVID-19 Delta Variant

TEL AVIV, Israel and RALEIGH, N.C., Aug. 26, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced preliminary results of a new preclinical study showing strong inhibiti...

2021-08-26 19:50 3963

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

HYDERABAD, India, Aug. 26, 2021 /PRNewswire/ -- Sai Life Sciences, a leading globalContract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that it has become a signatory of the Uni...

2021-08-26 19:19 4001

XABT Donates 2019-nCoV Nucleic Acid Detection Kits to Vientiane, Laos

BEIJING, Aug. 25, 2021 /PRNewswire/ -- Atsaphangthong Siphandone, Mayor of Vientiane, the capital of Laos, recently issued an honorary certificate to Beijing Applied Biological Technologies (XABT) for the donation of 2019-nCoV Nucleic Acid Detection Kits to supportVientiane's efforts at epidemic ...

2021-08-25 22:06 4939

Innovent Announced 2021 Interim Results with Total Revenue of RMB 1,941.8 Million and Accelerated Global R&D Footprint

SAN FRANCISCO and SUZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-08-25 20:53 5893

Tigermed Reports 2021 Interim Results with Strong Financial Growth

HANGZHOU, China, Aug. 25, 2021 /PRNewswire/ -- Hangzhou Tigermed Consulting Co., Ltd. (stock code: 300347.SZ / 3347.HK), a leading provider of innovative clinical research solutions for biopharmaceutical and medical device industry, reports its interim results for the six months endedJune 30, 202...

2021-08-25 20:49 6882

ExoCoBio to Build the World's First Clinical Grade Exosome GMP Manufacturing Facility

* $20 million investment for a new Mfg & R&D facility * Strategic platform for partnering & CDMO business SEOUL, South Korea, Aug. 25, 2021 /PRNewswire/ -- ExoCoBio Inc., the 4th largest exosome player in the world, announced the initiation of its "Project EGMP", starting with the constructio...

2021-08-25 19:44 3500

Angel Yeast Announces Acquisition of Bio Sunkeen's Yeast Relevant Assets

YICHANG, China, Aug. 25, 2021 /PRNewswire/ -- Angel Yeast Co., Ltd ("Angel Yeast ")(en.angelyeast.com ), a listed high-tech yeast company inChina, has recently announced it has established a joint venture company to investRMB 100 million ($15.4 million) to acquire Sha...

2021-08-25 19:35 5119

Global Cord Blood Corporation to Report First Quarter Fiscal 2022 Financial Results

HONG KONG, Aug. 25, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release financial results fo...

2021-08-25 19:00 3982

Brii Biosciences Announces Positive Data from the Phase 3 ACTIV-2 Trial Evaluating Combination BRII-196 and BRII-198 in Non-Hospitalized COVID-19 Patients

DURHAM, N.C. and BEIJING, Aug. 25, 2021 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national company developing innovative therapies for diseases with significant unmet medical need and large public health...

2021-08-25 08:42 3804

Advanced Sterilization Products Announces Launch in Asia Pacific of The Fastest Biological Indicator For Hydrogen Peroxide Sterilization

SINGAPORE, Aug. 25, 2021 /PRNewswire/ -- Advanced Sterilization Products (ASP) announced today that the STERRAD VELOCITY™ Biological Indicator (BI)/Process Challenge Device (PCD) 15-minute time to result will be commercially available in theAsia Pacific region# from 25 August 2021.

2021-08-25 08:10 4272

Athos Therapeutics Announces Research Collaboration with Cleveland Clinic to Advance Precision Medicine in Inflammatory Bowel Disease

LOS ANGELES, Aug. 25, 2021 /PRNewswire/ -- Athos Therapeutics, Inc., a late preclinical stage biotechnology company pioneering the development of first-in-class precision therapeutics for patients with immune-mediated diseases, announced today a comprehensive Master Research Agreement for a coll...

2021-08-25 01:00 3503

GenScript Biotech Reports First Half 2021 Results

* In the first half of 2021, the Group reported a revenue of approximately USD 229.6 million, a 38.0% YoY increase, and a gross profit of USD 138.6 million , achieving a 28.1% YoY growth. All four of the Group's business segments demonstrated steady growth. * Building on early strategic invest...

2021-08-24 21:38 6934

ASX Announcement: AdAlta and Carina Biotech to develop next-generation CAR-T cancer therapeutics

Highlights: * AdAlta and Carina Biotech enter a collaboration agreement to develop i-body enabled CAR-T cancer immunotherapies against up to five solid tumour antigen targets * Combining Carina's advanced CAR-T platform technologies with AdAlta's i–body targeting capability aims to create un...

2021-08-24 19:26 2510

Ascentage Pharma Announces 2021 Interim Results Highlighting the Potential of Its Core Drug Candidates and Major Breakthroughs in Strategic Collaborations

SUZHOU, China, and ROCKVILLE, Md., Aug. 24, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its 2021 interim results and released an updat...

2021-08-24 19:06 3970

Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021

SUZHOU, China, Aug. 24, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited ("Kintor Pharma", HKEX: 9939), a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced today the company will review the interim results and business highlights on...

2021-08-24 17:04 2751

China Medical System Holdings Limited 2021 Interim Results Announcement

Business Performance Reached Record High Turnover Increased by 23.6% to RMB3,843.0 Million Profit Increased by 25.5% to RMB1,631.6 Million Industrial Investment Enables Innovation Incubation New Businesses Boost Future Development Financial Highlights For the 6 months ended 30 June 2021 (RMB ...

2021-08-24 10:52 4454

Antengene Announces Approval of the Phase II Study of Selinexor for the Treatment of Myelofibrosis in China

SHANGHAI and HONG KONG, Aug. 24, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncol...

2021-08-24 08:30 3642

Genscript Biotech Reports 2021 Interim Financial Results

Strong Momentum across All Business Segments, particularly in Gene & Cell Therapy CDMO Continue to accelerate R&D investment to capture Future Growth * Revenue of the Group for the six months ended June 30, 2021 was approximately US$229.6 million, representing an increase of 38.0% as compared...

2021-08-24 01:32 4685

Himalaya Therapeutics Announces Registration of its Office in Shanghai

SHANGHAI and SAN DIEGO, Aug. 23, 2021 /PRNewswire/ -- Himalaya Therapeutics  ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization inGreater China, of a novel class of investigational antibody therapeutics for the treatment of solid tumor cancer, wh...

2021-08-23 22:10 2583
1 ... 329330331332333334335 ... 349